Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00446355 · ClinicalTrials.gov registry record
Clinical Outcomes of Patients With Clostridium Difficile Associated Disease Attributable to Diverse tcdC Genotypes
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT00446355 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 1,000 participants.
The verdict
NCT00446355 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
The purpose of the study is to establish the clinical disease outcomes and features of CDAD associated with variant tcdC genotypes. Two hypotheses are to be tested in this study: 1. Severe CDAD and tcdC truncation: Severe CDAD (defined by death and/or colectomy or secondary endpoints) is associated with severe truncations (\> 6 amino acid residues) in TcdC, a negative regulator of toxin A/B production. 2. Disease in low risk populations (patients never exposed to health care facilities and/or patients who never received antibiotics) of any severity is attributable to strains of C. difficile with severe tcdC truncation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2007-02 |
| Est. Completion | 2009-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00446355
The ClinicalTrials.gov registry entry for NCT00446355 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00446355 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00446355 about?
NCT00446355 is a clinical study titled "Clinical Outcomes of Patients With Clostridium Difficile Associated Disease Attributable to Diverse tcdC Genotypes". The purpose of the study is to establish the clinical disease outcomes and features of CDAD associated with variant tcdC genotypes. Two hypotheses are to be tested in this study: 1. Severe CDAD and tcdC truncation: Severe CDAD (defined by death and/or colectomy or secondary endpoints) is associ...
What is the current status of trial NCT00446355?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2007-02. Estimated completion is 2009-04.
Who is sponsoring clinical trial NCT00446355?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.